The effects of a set of conditions on aminoglycoside uptake were determined. Membrane vesicles either with a membrane potential (A0,) of -125 mV (adequate to drive lysine uptake) or with succinate, lactate, or phenazine methosulfate did not accumulate gentamicin unless components of protein synthesis were included. Ribosomally resistant (rpsL) Escherichia coli cells demonstrated energy-dependent phase II uptake similar to that of a streptomycin-susceptible strain of E. coli when treated with 100 ,ug of puromycin per ml. Puromycin (100 ,ug/ml) also increased the uptake of the cationic compounds polyamine and arginine. These studies support a role of protein synthesis in aminoglycoside uptake and in the development of energy-dependent phase II. A* of cells did not increase either at the initiation of or during energy-denpendent phase II, showing that energydependent phase II is not due to an elevation of A+. In a Bacillus subtilis system, significant streptomycin uptake requires a threshold value of A* which varies depending upon the concentration of streptomycin used. At 25 ,ug/ml, the uptake of streptomycin reached maximal levels after exceeding the threshold value, whereas at 100 p.g/ml there was a gradual increase of the uptake to the maximal after the threshold value was exceeded. Several studies supported the view that electron transport has a specific role other than its requirement to produce the cellular &*. The uptake of gentamicin was stimulated to a greater extent by phenazine methosulfate-ascorbate than by the ionophore nigericin in strains of E. coli, although nigericin stimulated Ai, to a greater degree. Cells with 25% of the normal quinone concentration had values identical to cells with the normal quinone concentration, but the quinone-deficient cells had a significantly lower rate of gentamicin uptake. KCN prevented gentamicin uptake but did not prevent the development of A+. The effects of ubiquinone depletion in an E. coli strain were more evident on gentamicin uptake than on ATP-driven glutamine transport or proton motive force-driven proline transport, consistent with a specific requirement for quinones in aminoglycoside uptake. A detailed explanation of the mechanism of accumulation of streptomycin and gentamicin and a proposed mechanism for killing bacterial cells by these agents have been provided.
The effects of a set of conditions on aminoglycoside uptake were determined. Membrane vesicles either with a membrane potential (A0,) of -125 mV (adequate to drive lysine uptake) or with succinate, lactate, or phenazine methosulfate did not accumulate gentamicin unless components of protein synthesis were included. Ribosomally resistant (rpsL) Escherichia coli cells demonstrated energy-dependent phase II uptake similar to that of a streptomycin-susceptible strain of E. coli when treated with 100 ,ug of puromycin per ml. Puromycin (100 ,ug/ml) also increased the uptake of the cationic compounds polyamine and arginine. These studies support a role of protein synthesis in aminoglycoside uptake and in the development of energy-dependent phase II. A* of cells did not increase either at the initiation of or during energy-denpendent phase II, showing that energydependent phase II is not due to an elevation of A+. In a Bacillus subtilis system, significant streptomycin uptake requires a threshold value of A* which varies depending upon the concentration of streptomycin used. At 25 ,ug/ml, the uptake of streptomycin reached maximal levels after exceeding the threshold value, whereas at 100 p.g/ml there was a gradual increase of the uptake to the maximal after the threshold value was exceeded. Several studies supported the view that electron transport has a specific role other than its requirement to produce the cellular &*. The uptake of gentamicin was stimulated to a greater extent by phenazine methosulfate-ascorbate than by the ionophore nigericin in strains of E. coli, although nigericin stimulated Ai, to a greater degree. Cells with 25% of the normal quinone concentration had values identical to cells with the normal quinone concentration, but the quinone-deficient cells had a significantly lower rate of gentamicin uptake. KCN prevented gentamicin uptake but did not prevent the development of A+. The effects of ubiquinone depletion in an E. coli strain were more evident on gentamicin uptake than on ATP-driven glutamine transport or proton motive force-driven proline transport, consistent with a specific requirement for quinones in aminoglycoside uptake. A detailed explanation of the mechanism of accumulation of streptomycin and gentamicin and a proposed mechanism for killing bacterial cells by these agents have been provided.
The uptake of the aminoglycoside antibiotics streptomycin and gentamicin has been shown to be influenced by a complex set of conditions. It has been shown that the kinetics of uptake involve an initial energy-independent phase associated with ionic binding to the cell surface and cytoplasmic membrane. This is followed by two energy-dependent phases, a slow initial rate of uptake termed energy-dependent phase I (EDP-I) and a second accelerated rate termed energy-dependent phase II (EDP-II). Initiation of the latter phase requires binding to ribosomes (reviewed in references 2 and 11) .
The most effective energy source has been demonstrated to be electron transport involving quinone oxidation-reduction cycles. Evidence has been provided that the bacterial transmembranous electrical potential (A*) (interior of cell, negative) is the driving force (3, 4, 8, 9) for aminoglycoside entry. A model coordinating these events and explaining the role of anaerobiosis and the effects of aminoglycoside modification by aminoglycoside-modifying enzymes has been developed by our group (2) (3) (4) 10) . The studies reported here were designed to test the model further and to provide more information to help answer several remaining important questions. Those questions include the relationship of aminoglycoside uptake to the size of A*, greater specificity as to the role of electron transport, further information on the transporter species used by aminoglyposides, and an explanation for EDP-II.
We ha-ve used the results obtained in this study to coordinate the roles of aminoglycoside Uptake and pertubation of the ribosomal cycle and protein synthesis in our model to provide an explanation for aminoglycoside lethality.
MATERIALS AND METHODS Strin. Strains used were Escherichia coli AN384 ubiA420 menA401 rpsL, AN387 rpsL, and SA1306 pro met nal.
Media. Media used were tryptic soy broth (GIBCO Laboratories), nutrient broth (BBL Microbiology Systems), minimal salts medium (25) , and gelysate-succinate aminoglycoside uptake medium consisting of 0.5% gelysate (BBL), 0.05 M Tris, and 10 mM sodium succinate (final pH, 7.0).
Uptake of sreptomycn (dihydrostreptomycin), gentmidn, glutmine, prollne, spenniin, and aqglbn. arginine, 340 mCi/mmol, 1.75 ,uM. For determination of streptomycin uptake in the presence of puromycin, streptomycin uptake was measured as previously described (6) . In those preparations to which puromycin was added, the drug was added at zero time with streptomycin. Final concentrations of puromycin tested were 50, 100, 200, 500, and 1,000 pg/ml. Puromycin at 100 ,g/ml produced maximal streptomycin uptake. Growth inhibitory effects of puromycin were followed by a comparison of growth rates of E. coli AN384 and AN387 in the presence and absence of puromycin at 100 &g/ml. Puromycin produced clearly detectable deviations from logarithmic growth under these conditions for both E. coli AN384 and AN387. The effect of puromycin uptake on spermidine and arginine was also determined by adding puromycin at zero time. Formation of membrae sead easurement of uptake Into vesides. The spheroplast formation method described by Weiss (27) was used for the preparation of spheroplasts, and the method described by Kabeck (17) was used for the preparation of membrane vesicles. Potassium-loaded vesicles were formed as described by Hirata et al. (13) .
Membrane vesicles containing components of protein synthesis were formed by suspension of membrane preparaoi_ns into a solution of 0.1 M phosphate buffer (pH 6.6) containing 10 mM EDTA at a protein concentration of 22 mg/ml. Ribosome fractions and the 30,000 x g supernatant were prepared as described by Modolell (20) , using a buffer consisting of 50 mM Trishydrochloride (pH 7.8), 60 mM NH4Cl, 15 mM magnesium acetate, and 6 mM 2-mercaptoethanol. The final protein concentration of the ribosomal preparation and the 30,000 x g supernatant was 10 mg/ml. The 30,000 x g supernatant was enriched by the addition of 5 mM creatine phosphate, 50 p.g of creatine kinase per ml, 0.8 mg of E. coli K-12 transfer RNA per ml, 0.1% Casamino Acids (if added), 6.6 x 10-2 M ATP, 10-3 M GTP, and 100 ,ug of polyuridylic acid per ml. In some experiments, a 2x-concentrated ribosomal preparation was added to the 2x-concentrated, enriched 30,000 x g supematant to obtain a final concentration of 10 mg of protein per ml of 30,000 x g supernatant and ribosomes. Equal amounts of the membrane preparation and either the ribosomal preparation or enriched 30,000 x g supernatant or the combined enriched 30,000 x g supernatant and ribosomal preparation or the enriched 30,000 x g supernatant minus Casamino Acids were mixed. Vesicles were allowed to form under these conditions at 48°C for 10 min. Preparations were chilled in ice, centrifuged at 30,000 x g for 10 min, and washed one time with 0.4 M sucrose-5 mM MgSO4. 7H20. Vesicles were further suspended and uptake was determined as described previously (16, 19) , using a final concentration of 100 or 200 F.g of gentamicin per ml and modifying the procedure to wash vesicles on membrane filters as described for dihydrostreptomycin and gentamicin uptake (5, 6).
Induction of A* into membrane vesicks. Potassiumloaded vesicles were formed as described previously (13) . Resuspended vesicles were treated by the addition of 10 pd of valinomycin dissolved in 95% ethanol (200 or 400 .g/ml) to obtain a final concentration of 2 or 4 ILg/ml. The valinomycin-ethanol mixture or 10 RI of 95% ethanol (control) was added to the vesicle preparation at the times indicated in Fig. 4 . Thereafter, lysine and gentamicin uptake in the vesicles was measured as described previously (16, 19) except that in the case of gentamicin uptake the washing procedure was that described for gentamicin uptake (5 concentration in nutrient broth containing a final concentration of 0.5 mM EDTA. For aminoglycoside uptake, the aminoglycoside was added simultaneously with either nigericin or the preparation of PMS-ascorbate. For TPP uptake, TPP was added immediately before the addition of nigericin or PMS-ascorbate. For quinone-sufficient cells, growth and uptake were carried out in nutrient broth containing 1 mM 4-hydroxybenzoate. Quinone-deficient cells were allowed to undergo two cell generations at 37°C in nutrient broth. Under these circumstances, cells contained approximately 25% of the normal content of quinone.
To determine the effect of gentamicin on A+, the following protocol was used. E. coli AN384 was grown in nutrient broth supplemented with 4-hydroxybenzoate from a starting A6w reading of 0.1 to a final reading of 0.4. Cells were centrifuged at 3,000 x g and suspended in nutrient broth at an A6w reading of about 0.4. These cells were treated for 2 min at 30°C with EDTA at a final concentration of 10 mM. Cells were washed with nutrient broth and suspended to the original optical density. Preparations were divided into a control and a gentamicin pretreatment sample. The control was incubated in nutrient broth containing 0.5 mM EDTA for 20 min at 30°C. Cells were washed with nutrient broth and suspended to an optical density of about 2 for TPP uptakes. The gentamicin pretreatment sample was suspended in nutrient broth containing 0. pg/ml were added; to the third a final concentration of 10 Fg of tritiated gentamicin per ml was added. TPP uptake was measured from the first and second preparations, and gentamicin uptake was measured from the third preparation.
Electron transport and energy coupling. Oxygen consumption as a measure of electron transport was determined as previously described (4) . Cytochrome spectra and quinone contents were determined as described previously (4, 22) .
A* and potassium concentration in Bacillus subilis.
Shioi et al. (24) previously described a method of manipulating the A* and ApH components of the proton motive force. We modified this method so that there was a linear relationship between the extracellular potassium concentration and A* at a lower ionic strength than described by Shioi et al. (24) . The medium used was the gelysate-succinate medium containing 10 mM succinate. To this, different combinations of potassium chloride and sodium chloride were added to obtain a final concentration of 25 mM potassium or sodium. TPP uptake and A* were determined as described above. Dihydrostreptomycin uptake was determined at concentrations of 25 and 100 p,g/ml as described above.
RESULTS
Components of protein synthesis and aminoglycoside uptake. Previous studies have shown that the development of EDP-II of streptomycin transport can be'prevented by the use of rpsL mutants (6) . R-factors which specify streptomycin adenylylation and reduce ribosomal affinity for streptomycin are associated with absent or reduced EDP-II transport (10) . Similar findings occur with gentamicin acetylation (L. E. Bryan, unpublished data). These studies demonstrated that ribosomal binding contributes significantly to the total uptake of streptomycin or gentamicin. Figure 1 illustrates the uptake of gentamicin, using membrane vesicles derived from E. coli formed in the presence of components of protein synthesis. Vesicles did not accumulate gentamicin unless both an energy source and all of the components needed to establish protein synthesis were present. We did not establish whether protein synthesis actually occurred under these circumstances. Removal of amino acids, the ribosome preparation, or the 30,000 x g supernatant or the addition of 1 mM KCN prevented gentamicin uptake.
Membrane vesicles (without protein synthesis components) with succinate, lactate, or PMS as energy sources accumulated proline and lysine Hurwitz and colleagues have previously shown that E. coli rpsL mutants show accelerated uptake of streptomycin when treated with selected concentrations of puromycin (15) . Results shown in Fig. 2 confirm that observation and that streptomycin uptake in a puromycintreated rpsL mutant is very similar to that of a streptomycin-susceptible strain. Higher (200, 500, and 1,00 ,ug/ml) or lower (50 4g/ml) puromycin concentrations produced lower rates of streptomycin uptake. Also shown in Fig. 2 is the dependence of the enhanced uptake produced by puromycin on electron transport in that cells with <1% the ubiquinone content of the wild type did not show the effect of puromycin.
Puromycin was equally effective at inhibiting cell growth in ubiquinone-deficient or -sufficient strains, demonstrating that quinone deficiency did not alter puromycin entry.
The effect of puromycin was not limited to streptomycin. The rates of accumulation of the polyamine spermidine and the cationic amino acid arginine were also increased by treatment of cells with 100 Rg of puromycin per ml (Fig. 3 ).
Au and gentamicin uptake. Evidence has been provided that the electrically negative AV of bacterial cells is the driving force for gentamicin and streptomycin entry (3, 9) . Figure 4 shows the results of uptake of gentamicin and the cationic amino acid lysine into K+-rich vesicles treated with valinomycin to induce A+s. As shown, there was a rapid influx of lysine but no detectable uptake of gentamicin. Shioi et al. (24) have described a system in which B. subtilis is used that allows the manipulation of components of the proton motive force. We previously used this system to relate A4 to gentamicin uptake (3) . In those preliminary stud- ies, we found that a threshold of LI, was required to produce gentamicin uptake with no increase in uptake with a further increase in A+. The disadvantage of the system was that the gentamicin uptake obtained was poor due to the high ionic strength used in the system. We report here the development of a modified system that allows the manipulation of AL at a much lower ionic strength, which was a condition favorable to aminoglycoside uptake. Figure 5 shows (14) as well as the cationic amino acid arginine (4). These observations are also found with puromycin treatment of cells (Fig. 3) . Data in Fig. 6 and 7 show that rather than an increase in the uptake of TPP associated with the onset of EDP-II for gentamicin, there was a decrease in A* whether TPP uptake was measured with gentamicin present (Fig. 6 ) or after pretreatment with gentamicin (Fig. 7) . Thus, EDP-II cannot be caused by an increase in A+.
Is electron transport required for amioglyc side uptake only to produce A*. It is possible that the requirement for electron transport needed for significant gentamicin uptake is due to its being the most effective means of producing A,.
To determine whether electron transport works entirely through creation of lA, or whether it has a specific role in aminoglycoside transport, we determined gentamicin uptake with PMS-ascorbate. In these experiments, we compared the gentamicin uptake induced by PMS-ascorbate with the uptake produced by the ionophore nigericin, which produced greater values of A* than those produced by PMS-ascorbate.
To compare rates of electron transport and A*i with strains of E. coli, it was necessary to determine an EDTA concentration that allowed access of nigericin and TPP to the cytoplasmic membrane but did not significantly alter gentamicin uptake. A final concentration of 0.5 mM EDTA in uptake mixtures was determined to meet these requirements. Results (Fig. 8) demonstrate that PMS-ascorbate stimulated uptake both in quinone-sufficient cells of E. coli AN384 and in cells depleted to about 25% of the usual quinone concentration (quinone-deficient cells) (cf. Fig. 8A with B) . In contrast, although nigericin stimulated AL to values greater than those obtained with PMSascorbate ( Fig. 8B and C) , there was no stimulation of gentamicin uptake in quinone-sufficient or -deficient cells (Fig. 8A and C) .
Quinone-sufficient and -deficient cells demonstrated similar AL values under all conditions examined but showed significantly different rates of gentamicin uptake (Fig. 8A, B, and C) .
These results support a specific role of electron.transport distinct from the development of 4I.
VOL. 23, 1983 on We examined the effect of 5 mM KCN on the uptake of TPP and gentamicin associated with the use of PMS-ascorbate (Fig. 9) . KCN use inhibited almost all gentamicin uptake but was still associated with the uptake of TPP and the development of A+. Unlike the pattern of TPP uptake seen in the absence of KCN, a loss of TPP occurred in later samples, suggesting a gradual loss of Ai. However, the inhibitory effect was much greater on gentamicin uptake than on A,.
The relationship in E. coli AN384 among ubiquinone content, ATP-driven glutamine transport, proton motive force-driven proline transport, cytochrome content, 02 consumption, and gentamicin uptake is given in Table 1 . These data show that glutamine transport was independent of the quinone concentration to at least a reduction to 6% of that normally found. Proline transport was reduced at low quinone concentrations but is still about 70% of the rate seen with the normal amount of quinones. In contrast, gentamicin transport fell off markedly at 25% or lower quinone ratios. These findings illustrate the unique dependence of aminoglycoside uptake on quinone-associated electron transport in bacteria.
DISCUSSION
The results reported in this series of studies are consistent with results predicted by our model of aminoglycoside uptake (1, 2). An updated version of that model is explained in Fig.  10 . Support for this comprehensive model is now strong. Nakae and Nakae recently provided good evidence that aminoglycosides penetrate the outer membrane of gram-negative bacteria such as E. coli through the aqueous pores formed by porin proteins (21) . The only current exception to this seems to be Pseudomonas aeruginosa, where aminoglycosides likely disrupt the outer membrane as a mode of penetration (12) .
Transmission across the cytoplasmic membrane is clearly dependent on A4 (3, 9) , as predicted in the model. However, some questions had not been fully answered. What is the relationship of the magnitude of A4 and the rate of aminoglycoside transport? Does electron transport have a direct role in aminoglycoside transport in addition to its role in the development of A+? What is the nature of the species acting as the membranous transporter for aminoglycosides? Why does the transport rate increase (EDP-II) after initial EDP-I transport?
Previously it was proposed that the transporter responsible for EDP-II was a polyamine transport system (14) . This proposal was based on the acceleration of polyamine transport associated with the onset of EDP-II. However, there is little evidence to support this proposal. Polyamines do not induce streptomycin (14) or gentamicin uptake (4), mutants exist with differential effects on polyamine and aminoglycoside uptake (7) , and a new or increased quantity of protein induced by streptomycin cannot be demonstrated (1). These findings argue effectively against the polyamine transport system. Streptomycin and gentamicin are not saturable transport systems in normal bacteria, and the transport system has diffusion kinetics. Again, this argues against a specific carrier system being involved (but does not exclude multiple carrier systems).
Results in this study demonstrate that there is a role in aminoglycoside transport for electron transport outside of its requirement to develop A+. This has been shown by PMS-ascorbate being more effective than nigericin in stimulating aminoglycoside uptake despite a smaller change in A,. It has also been supported by the different The direct role of electron transport clearly is related to quinone content. Our results provide further evidence for a direct role of quinones but do not confirm that they are the transporter. The pleiotrophic effects of the reduction of the quinone content makes a final statement on quinones very difficult indeed. Figure 10 is a diagrammatic representation of a model of the processes involved in aminoglycoside uptake and lethality. The following is an explanation of the processes proposed to account for the uptake and lethality.
The polycationic aminoglycoside molecule (+Ag') binds to negative charges on the cell surface and passes through water-filled spaces (porin-formed pores in gram-negative bacteria [21] 12 ing. We propose that lethality results from a Minte gradual disruption of membrane integrity and, 9. Gentamicin uptake (10 F.g/ml) (A) and TPP subsequently, function due to the physical at 30°C by E. coli AN384 grown in nutrient forces involved in the transfer events. This is vith 1 mM 4-hydroxybenzoate. Uptakes of supported by the long-recognized loss of permeicin and TPP were determined in nutrient broth ability control due to aminoglycosides (11) . It in the presence of 1 mM PMS and 20 mM also explains the requirement for ribosomal te (X), with no additions (0), or with 1 mM binding and pertubation of protein synthesis to D mM ascorbate, and 5 mM KCN (U).
cause killing. The study of Hurwitz et al. (15) and our studies clearly show that EDP-II can be mimicked by puromycin, which produces at least some effects similar to streptomycin. We )f respiratory quinones. In P. aeruginosa have also shown that EDP-II is not due to an nembrane binding may disrupt the outer increase in A* (this study) and that both the ane and allow direct entry to the cyto-aminoglycoside-and puromycin-induced EDP-II ; membrane (12) . require quinones (2; this study). We have also e of the +Ag+ bound at cytoplasmic mem-shown that in membrane vesicles aminoglycolinds with a transporter species proposed side uptake did not occur in the presence of mobile respiratory quinone or a series of various energy sources or with A& adequate to irters linked to quinones. Electron trans-direct whole-cell uptake. It appeared to require required (this study) and is proposed to components needed for protein synthesis. These e a negative polarity of the transporter by results are fully consistent with our previous on. The bound +Ag+ is driven across the studies showing that EDP-II is prevented (or ane by a threshold value of A& (EDP-I) reduced) by rpsL mutations or by aminoglycos study). Some +Ag+ is transferred to side modification (6, 10) . nes that are part of polysomes (transfer To date, the vast majority of experimental and which act as a binding sink. Binding results are consistent with all major aspects of somes initiates pertubation of the ribo-our model explaining aminoglycoside accumulacycle and protein synthesis (reviewed in tion and lethality. In our view, it provides a full Ice 26), accelerating the rate of transfer understanding of the way that aminoglycosides to ribosomes (EDP-II) (15; this study). work. 
